Tselios K, Gladman DD, Touma Z, et al. Disease course patterns in systemic lupus ery-thematosus. Lupus. 2019;28:114–22. doi: 10.1177/0961203318817132.

Figueiredo-Braga M, Cornaby C, Cortez A, et al. Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors. Medicine. 2018;97(28):e11376. doi: 10.1097/MD.0000000000011376.

Zhang L, Fu T, Yin R, et al. Prevalence of depression and anxiety in systemic lupus ery-thematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):70. doi: 10.1186/s12888-017-1234-1.

Yao H, Yang H, Wang Y, Xing Q, Yan L, Chai Y. Gut microbiome and fecal metabolic alter-ation in systemic lupus erythematosus patients with depression. Front Cell Infect Micro-biol. 2022;12:1040211. doi: 10.3389/fcimb.2022.1040211.

Xiang S, Qu Y, Qian S, et al. Association between systemic lupus erythematosus and dis-ruption of gut microbiota: a meta-analysis. Lupus Sci Med. 2022;9(1): e000599. doi: 10.1136/lupus-2021-000599.

de Oliveira GLV, Leite AZ, Higuchi BS, et al. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology. 2017;152(1):1-12. doi: 10.1111/imm.12765.

Rogers GB, Keating DJ, Young RL, et al. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry. 2016;21(6):738-48. doi: 10.1038/mp.2016.50.

Taylor AM, Holscher HD. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. 2020;23(3):237-50. doi: 10.1080/1028415X.2018.1493808.

Chen Y, Lin J, Xiao L, et al. Gut microbiota in systemic lupus erythematosus: a fuse and a solution. J Autoimmun. 2022;132:102867. doi: 10.1016/j.jaut.2022.102867.

Yao K, Xie Y, Wang J, et al. Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus. Front Immunol. 2023;14:1202850. doi: 10.3389/fimmu.2023.1202850.

Pan Q, Guo F, Huang Y, et al. Gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies. Front Immunol. 2021;12:799788. doi: 10.3389/fimmu.2021.799788.

Jeon SW, Kim YK. Inflammation-induced depression: its pathophysiology and therapeutic implications. J Neuroimmunol. 2017;313:92-8. doi: 10.1016/j.jneuroim.2017.10.016.

Widhani A, Djauzi S, Suyatna FD, et al. Changes in gut microbiota and systemic inflam-mation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells. 2022;11(21):3419. doi: 10.3390/cells11213419.

Ardini W, Bardosono S. Using the dietary inflammatory index for assessing inflammatory potential of traditional cuisine from four ethnic groups in Indonesia. Journal of Food and Nutrition Research. 2020;8(4):168-71. doi: 10.12691/jfnr-8-4-2

Shivappa N, Steck SE, Hurley TG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689-96. doi: 10.1017/S1368980013002115

Kwan A, Marzouk S, Ghanean H, et al. Assessment of the psychometric properties of pa-tient-reported outcomes of depression and anxiety in systemic lupus erythematosus. Semin Arthritis Rheum. 2019;49(2) 260-6. doi: 10.1016/j.semarthrit.2019.03.004.

de Almeida Macêdo E, Appenzeller S, Lavras Costallat LT. Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in pa-tients with systemic lupus erythematosus. Rheumatol Int. 2017;37(12):1999-2004. doi: 10.1007/s00296-017-3819-x.

Moustafa AT, Moazzami M, Engel L, et al. Prevalence and metric of depression and anxi-ety in systemic lupus erythematosus: a systematic review and meta-analysis. Semin Ar-thritis Rheum. 2020;50(1):84-94. doi: 10.1016/j.semarthrit.2019.06.017. Epub 2019 Jun 28.

Bai R, Liu S, Zhao Y, et al. Depressive and anxiety disorders in systemic lupus erythema-tosus patients without major neuropsychiatric manifestations. J Immunol Res. 2016;2016:2829018. doi: 10.1155/2016/2829018.

Shatri H, Purnamandala, Hidayat R, et al. The correlation of anxiety and depression with C3 and C4 Levels and systemic lupus erythematosus activity. BMC Psychiatry. 2023;23(1):785. doi: 10.1186/s12888-023-05285-8.

Liu R, Xu H, Guo X, et al. Genomic characterization of two Escherichia fergusonii isolates harboring the mcr-1 gene from the farm environment. Front Cell Infect Microbiol. 2022;12:774494. doi: 10.3389/fcimb.2022.774494.

Chen Z, Xie Y, Zhou F, et al. Featured gut microbiomes associated with the progression of chronic hepatitis B disease. Front Microbiol. 2020;11:383. doi: 10.3389/fmicb.2020.00383.

Marciano F, Vajro P. Oxidative stress and gut microbiota. In: Gracia-Sancho J, Salvadó J, editors. Gastrointestinal Tissue. Academic Press; 2017. p.113-23. https://doi.org/10.1016/B978-0-12-805377-5.00008-4.

Zhao Y, Lukiw WJ. Bacteroidetes neurotoxins and inflammatory neurodegeneration. Mol Neurobiol. 2018;55(12):9100-7. doi: 10.1007/s12035-018-1015-y.

Gibiino G, Lopetuso LR, Scaldaferri F, et al. Exploring Bacteroidetes: metabolic key points and immunological tricks of our gut commensals. Dig Liver Dis. 2018;50(7):635-9. doi: 10.1016/j.dld.2018.03.016.

Toumi E, Mezouar S, Plauzolles A, et al. Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives. Lupus Sci Med. 2023;10(1):e000776. doi: 10.1136/lupus-2022-000776.

Zhang L, Qing P, Yang H, et al. Gut microbiome and metabolites in systemic lupus ery-thematosus: link, mechanisms, and intervention. Front Immunol. 2021;12:686501. doi: 10.3389/fimmu.2021.686501.

Krupa-Kotara K, Gwiozdzik W, Nandzik S, et al. The role of microbiota pattern in anxiety and stress disorders—a review of the state of knowledge. Psych. 2023;5:602–18. doi: 10.3390/psych5030038

Zhang Y, Gan M, He Y, et al. Anxiety disorders and gut dysbiosis in primary Sjogren's syn-drome-mediated dry eye patients. Int J Gen Med. 2023;16:1735-46. doi: 10.2147/IJGM.S405225.

Jacobs JP, Lagishetty V, Hauer MC, et al. Multi-omics profiles of the intestinal microbi-ome in irritable bowel syndrome and its bowel habit subtypes. Microbiome. 2023;11(1):5. doi: 10.1186/s40168-022-01450-5.

Ritz NL, Brocka M, Butler MI, et al. Social anxiety disorder- associated gut microbiota in-creases social fear. Proc Natl Acad Sci USA. 2024;121(1):e2308706120. doi: 10.1073/pnas.2308706120.

Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol. 2014;817:177-94. doi: 10.1007/978-1-4939-0897-4_8.

Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with ma-jor depressive disorder. Brain Behav Immun. 2015;48:186-94. doi: 10.1016/j.bbi.2015.03.016.

Nguyen TT, Kosciolek T, Maldonado Y, et al. Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects. Schizophr Res. 2019;204:23-9. doi: 10.1016/j.schres.2018.09.014.

Qing Y, Xu L, Cui G, et al. Salivary microbiome profiling reveals a dysbiotic schizophrenia-associated microbiota. NPJ Schizophr. 2021;7(1):51. doi: 10.1038/s41537-021-00180-1.

Mosca A, Leclerc M, Hugot JP. Gut microbiota diversity and human diseases: Should we reintroduce key predators in our ecosystem? Front Microbiol. 2016;7:1–12. doi: 10.3389/fmicb.2016.00455.

Chen J, Siliceo SL, Ni Y, et al. Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions. Microbiome. 2023;11(1):178. doi: 10.1186/s40168-023-01604-z.

Hiippala K, Kainulainen V, Kalliomäki M, et al. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Front Microbiol. 2016;7:1706. doi: 10.3389/fmicb.2016.01706.

Van den Abbeele P, Belzer C, Goossens M, et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013;7(5):949-61. doi: 10.1038/ismej.2012.158.

Zhang P. Influence of foods and nutrition on the gut microbiome and implications for in-testinal health. Int J Mol Sci. 2022;23(17):9588. doi: 10.3390/ijms23179588.

Kumar A, Pramanik J, Goyal N, et al. Gut microbiota in anxiety and depression: Unveiling the relationships and management options. Pharmaceuticals (Basel). 2023;16(4):565. doi: 10.3390/ph16040565.